128 related articles for article (PubMed ID: 7888019)
1. [Expression of calgranulin A and B in middle ear cholesteatoma].
Holly A; Bujía J; Lempart K; Serge M
Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
Holly A; Sittinger M; Bujía J
Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
[TBL] [Abstract][Full Text] [Related]
3. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of cytokeratins in retraction pocket cholesteatomas.
Kim HJ; Tinling SP; Chole RA
Laryngoscope; 2001 Jun; 111(6):1032-6. PubMed ID: 11404616
[TBL] [Abstract][Full Text] [Related]
5. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
6. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
[TBL] [Abstract][Full Text] [Related]
7. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
[TBL] [Abstract][Full Text] [Related]
9. [Autocrine growth mechanisms of cholesteatoma epithelium].
Schilling V; Holly A; Bujía J; Schulz P
Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
[TBL] [Abstract][Full Text] [Related]
10. Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma.
Bayazít YA; Karakök M; Uçak R; Kanlíkama M
Laryngoscope; 2001 Jun; 111(6):1037-41. PubMed ID: 11404617
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
Holly A; Sittinger M; Bujia J
Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
[TBL] [Abstract][Full Text] [Related]
12. Survival signaling and terminal differentiation in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2007 Apr; 127(4):424-9. PubMed ID: 17453465
[TBL] [Abstract][Full Text] [Related]
13. Macrophage marker 27E10 on human keratinocytes helps to differentiate discoid lupus erythematosus and Jessner's lymphocytic infiltration of the skin.
Kunz M; Henseleit-Walter U; Sorg C; Kolde G
Eur J Dermatol; 1999 Mar; 9(2):107-10. PubMed ID: 10066957
[TBL] [Abstract][Full Text] [Related]
14. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
16. [Hyperproliferation-associated keratin 16 expression in cholesteatoma].
Schilling V; Bujía J; Holly A; Schulz P
Laryngorhinootologie; 1992 Nov; 71(11):584-7. PubMed ID: 1281411
[TBL] [Abstract][Full Text] [Related]
17. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
Holly A; Bujía J; Sanchez-Madrid F
Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
19. Heat shock proteins in middle ear cholesteatoma.
Shinoda H; Huang CC
Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation.
Martinsson H; Yhr M; Enerbäck C
Exp Dermatol; 2005 Mar; 14(3):161-8. PubMed ID: 15740587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
